Berg Pharma Mines DoD Prostate Data For Biomarkers, Drug Targets
This article was originally published in The Pink Sheet Daily
Executive Summary
Berg will use its Interrogative Biology/AI technology to sort 27,000 records, including thousands of biosamples, in a search for prognostic markers and clues to the biology of prostate cancer.